Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ID: DRG0KPJEU)
ADC Name
39948340 ADC 3 (nobinding)
Synonyms
ADC 3 (nobinding)
   Click to Show/Hide
Organization
Bristol-Myers Squibb.
Drug Status
Investigative
Structure
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
TLR7 payload 1
  Payload Info 
Linker Name
39948340 Linker
  Linker Info 
Conjugate Type
Direct preparation of site-specific ADC with unpurified antibodies in culture medium.
2027 Update
General Information of The ADMET Data Related to This ADC
Absorption
Click To Hide/Show 12 Absorption Data Related to This Level
Standard Type Value Units Description Reference
Time to Maximum Concentration (Tmax) 0.25 h
Pharmacokinetic (PK) parameters of ADC at a dose of 10 mpk in CT26 tumor mice.
 [1]
Time to Maximum Concentration (Tmax) 0.25 h
Pharmacokinetic (PK) parameters of ADC at a dose of 30 mpk in CT26 tumor mice.
 [1]
Time to Maximum Concentration (Tmax) 0.25 h
Pharmacokinetic (PK) parameters of ADC at a dose of 1 mpk in CT26 tumor mice.
 [1]
Maximum Observed Concentration (Cmax) 142 ug/mL
Pharmacokinetic (PK) parameters of ADC at a dose of 10 mpk in CT26 tumor mice.
 [1]
Maximum Observed Concentration (Cmax) 354 ug/mL
Pharmacokinetic (PK) parameters of ADC at a dose of 30 mpk in CT26 tumor mice.
 [1]
Maximum Observed Concentration (Cmax) 13.2 ug/mL
Pharmacokinetic (PK) parameters of ADC at a dose of 1 mpk in CT26 tumor mice.
 [1]
Area Under the Concentration-Time Curve (AUC) 8584 h·ug/mL
Pharmacokinetic (PK) parameters of ADC at a dose of 10 mpk in CT26 tumor mice, AUClast.
 [1]
Area Under the Concentration-Time Curve (AUC) 22944 h·ug/mL
Pharmacokinetic (PK) parameters of ADC at a dose of 30 mpk in CT26 tumor mice, AUClast.
 [1]
Area Under the Concentration-Time Curve (AUC) 31 h·ug/mL
Pharmacokinetic (PK) parameters of ADC at a dose of 1 mpk in CT26 tumor mice, AUClast.
 [1]
Area Under the Concentration-Time Curve (AUC) 9329 h·ug/mL
Pharmacokinetic (PK) parameters of ADC at a dose of 10 mpk in CT26 tumor mice, AUCinf.
 [1]
Area Under the Concentration-Time Curve (AUC) 25597 h·ug/mL
Pharmacokinetic (PK) parameters of ADC at a dose of 30 mpk in CT26 tumor mice, AUCinf.
 [1]
Area Under the Concentration-Time Curve (AUC) 372 h·ug/mL
Pharmacokinetic (PK) parameters of ADC at a dose of 1 mpk in CT26 tumor mice, AUCinf.
 [1]
Distribution
Click To Hide/Show 3 Distribution Data Related to This Level
Standard Type Value Units Description Reference
Volume of Distribution (Vd) 110 mL/kg
Pharmacokinetic (PK) parameters of ADC at a dose of 10 mpk in CT26 tumor mice.
 [1]
Volume of Distribution (Vd) 135 mL/kg
Pharmacokinetic (PK) parameters of ADC at a dose of 30 mpk in CT26 tumor mice.
 [1]
Volume of Distribution (Vd) 90.6 mL/kg
Pharmacokinetic (PK) parameters of ADC at a dose of 1 mpk in CT26 tumor mice.
 [1]
Excretion
Click To Hide/Show 6 Excretion Data Related to This Level
Standard Type Value Units Description Reference
Elimination Half-Life (t1/2) 70.9 h
Pharmacokinetic (PK) parameters of ADC at a dose of 10 mpk in CT26 tumor mice.
 [1]
Elimination Half-Life (t1/2) 83.5 h
Pharmacokinetic (PK) parameters of ADC at a dose of 30 mpk in CT26 tumor mice.
 [1]
Elimination Half-Life (t1/2) 23.8 h
Pharmacokinetic (PK) parameters of ADC at a dose of 1 mpk in CT26 tumor mice.
 [1]
Clearance (CL) 26.2 mL/day/kg
Pharmacokinetic (PK) parameters of ADC at a dose of 10 mpk in CT26 tumor mice.
 [1]
Clearance (CL) 28.2 mL/day/kg
Pharmacokinetic (PK) parameters of ADC at a dose of 30 mpk in CT26 tumor mice.
 [1]
Clearance (CL) 64.7 mL/day/kg
Pharmacokinetic (PK) parameters of ADC at a dose of 1 mpk in CT26 tumor mice.
 [1]
References
Ref 1 Targeted Delivery of TLR7 Agonists to the Tumor Microenvironment Enhances Tumor Immunity via Activation of Tumor-Resident Myeloid Cells